Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Minying Li
Observed name:
M. Li
Institutions:
Zhongshan People's Hospital,
Peking University First Hospital
Observed institutions:
University Health Network,
Princess Margaret Cancer Centre,
Zhongshan People's Hospital,
Peking University First Hospital
ORCID:
0009-0002-0487-6336
Observed ORCID:
0009-0002-0487-6336
OpenAlex ID:
A5081439738
Ferroptosis-Associated Extracellular Matrix Remodeling in Radiation-Induced Lung Fibrosis Progression
2024
·
Xinyu Yan
, Peixuan Yang
, et al.
·
Dose-Response
·
8
909P A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy: Updated results
2021
·
X. Chen
, C. Hu
, et al.
·
Annals of Oncology
·
7
0912 Dupilumab unmasking cutaneous γδ T cell lymphoma through promoting tumorous T cell aggressiveness and microenvironment reprogramming
2025
·
M. Li
, Y. Xiao
, et al.
·
Journal of Investigative Dermatology
·
1
Abstract 4686: Efficacy and safety of efbemalenograstim alfa as primary prophylaxisfor concurrent chemo-radiotherapy induced neutropenia
2025
·
Yuanyuan Chen
, Qiwen Li
, et al.
·
Cancer Research
·
1
252P Impact of informative censoring on the interpretation of progression-free survival (PFS) estimates in phase III randomized trials (RCT) in metastatic breast cancer (MBC)
2024
·
Y. Berner Wygoda
, D. Malón Giménez
, et al.
·
ESMO Open
·
1
PDF
Neoadjuvant Pertuzumab Biosimilar HLX11 versus Reference Pertuzumab for Early-Stage or Locally Advanced Breast Cancer: A Phase III Equivalence Trial
2026
·
Jin Zhang
, Jinhai Zhu
, et al.
·
Clinical Cancer Research
0731 Malignant T cells undergo metabolic reprogramming by creating a metabolic bypass through glucose-1,6-bisphosphate synthase PGM2L1 in cutaneous T cell lymphoma
2025
·
Y. Wen
, Y. Jiang
, et al.
·
Journal of Investigative Dermatology
PDF
0070 Single-cell RNA sequencing informs enhanced antitumor immunity after brentuximab vedotin and combination strategy in mycosis fungoide
2025
·
Y. Jiang
, M. Li
, et al.
·
Journal of Investigative Dermatology
PDF
1877P Adverse effects (AEs) of trastuzumab deruxtecan (T-DXd) in solid tumours: A meta-analysis
2024
·
N. Pathak
, M.R. Di Iorio
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
9
Citation count:
18
H-index:
2
I10-index:
Year
Topic
Type